# Observational Program to Assess Routine Use of Add-back Therapy in Patients With Endometriosis in Russian Federation, Planned for 6-month Course of Lucrin Depot® (Leuprorelin)

> **NCT01294371** · — · COMPLETED · sponsor: **AbbVie (prior sponsor, Abbott)** · enrollment: 391 (actual)

## Conditions studied

- Genital Endometriosis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01294371
- **Lead sponsor:** AbbVie (prior sponsor, Abbott)
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-02
- **Primary completion:** 2012-05
- **Final completion:** 2012-05
- **Target enrollment:** 391 (ACTUAL)
- **Last updated:** 2013-07-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01294371

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01294371, "Observational Program to Assess Routine Use of Add-back Therapy in Patients With Endometriosis in Russian Federation, Planned for 6-month Course of Lucrin Depot® (Leuprorelin)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01294371. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*